Chemours Company (NYSE:CC) currently has a daily average trading volume of 3.63M but it saw 4348916 shares traded in last market. With a market cap of 1.62B USD, the company’s current market price of $10.85 came rising about 2.94 while comparing to the previous closing price of $10.54. In past 52 weeks, the stock remained buoying in the range of price level as high as $27.65 and as low as $9.33.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Mizuho which upgraded the stock as “Outperform” in its note to investors issued on March 27, 2025, recommending a price target of $19 for it. UBS also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $28 and $30.
Over the week, CC’s stock price is moving -1.72% down while it is -8.28% when we observe its performance for the past one month. Year-to-date it is -35.80% down and over the past year, the stock is showing a downside performance of -62.50%.
Currently, Chemours Company’s total number of outstanding shares is 149.57M. Company’s return on investment (ROI) stands at 0.64% and return on equity (ROE) at 4.66%. It has a price to earnings ratio (P/E ratio) of 52.72 while having a 4.45 of forward P/E ratio. Stock’s beta reads 1.66. Stock has a price to book (P/B) ratio of 2.80 while price to sale or P/S ratio amounts to 0.28. Its return on asset (ROA) is 0.40% on average.
